These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation]. Landolsi S; Gharbi O; Zrig M; Gribaa M; Njim L; Zakhama A; Abid A; Frébourg T; Ahmed SB Ann Biol Clin (Paris); 2010; 68(3):346-50. PubMed ID: 20478780 [TBL] [Abstract][Full Text] [Related]
4. Identification of a novel TP53 germline mutation in a large Italian Li-Fraumeni syndrome Family. Capra V; Consales A; Nozza P; Monti P; Inga A; Fronza G Pediatr Blood Cancer; 2009 Feb; 52(2):303-4. PubMed ID: 18937320 [No Abstract] [Full Text] [Related]
5. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995 [TBL] [Abstract][Full Text] [Related]
6. High frequency of de novo mutations in Li-Fraumeni syndrome. Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618 [TBL] [Abstract][Full Text] [Related]
7. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome. Barlow JW; Mous M; Wiley JC; Varley JM; Lozano G; Strong LC; Malkin D Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1403-6. PubMed ID: 15298965 [TBL] [Abstract][Full Text] [Related]
8. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457 [TBL] [Abstract][Full Text] [Related]
9. Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome. Rieber J; Remke M; Hartmann C; Korshunov A; Burkhardt B; Sturm D; Mechtersheimer G; Wittmann A; Greil J; Blattmann C; Witt O; Behnisch W; Halatsch ME; Orakcioglu B; von Deimling A; Lichter P; Kulozik A; Pfister S Genes Chromosomes Cancer; 2009 Jul; 48(7):558-68. PubMed ID: 19378321 [TBL] [Abstract][Full Text] [Related]
10. Early detection of adrenocortical carcinoma in a child with Li-Fraumeni syndrome. Lin MT; Shieh JJ; Chang JH; Chang SW; Chen TC; Hsu WH Pediatr Blood Cancer; 2009 Apr; 52(4):541-4. PubMed ID: 19101993 [TBL] [Abstract][Full Text] [Related]
11. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations. Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465 [TBL] [Abstract][Full Text] [Related]
12. A novel TP53 germline mutation in a family with a history of multiple malignancies: case report and review of the literature. Agarwalla PK; Dunn IF; Turner CD; Ligon KL; Schneider KA; Smith ER Pediatr Neurosurg; 2008; 44(6):501-8. PubMed ID: 19127094 [TBL] [Abstract][Full Text] [Related]
13. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Birch JM; Blair V; Kelsey AM; Evans DG; Harris M; Tricker KJ; Varley JM Oncogene; 1998 Sep; 17(9):1061-8. PubMed ID: 9764816 [TBL] [Abstract][Full Text] [Related]
14. Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010. Gozali AE; Britt B; Shane L; Gonzalez I; Gilles F; McComb JG; Krieger MD; Lavey RS; Shlien A; Villablanca JG; Erdreich-Epstein A; Dhall G; Jubran R; Tabori U; Malkin D; Finlay JL Pediatr Blood Cancer; 2012 Jun; 58(6):905-9. PubMed ID: 21990040 [TBL] [Abstract][Full Text] [Related]
15. Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome. Palmero EI; Achatz MI; Ashton-Prolla P; Olivier M; Hainaut P Curr Opin Oncol; 2010 Jan; 22(1):64-9. PubMed ID: 19952748 [TBL] [Abstract][Full Text] [Related]
16. Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family. Varley JM; Chapman P; McGown G; Thorncroft M; White GR; Greaves MJ; Scott D; Spreadborough A; Tricker KJ; Birch JM; Evans DG; Reddel R; Camplejohn RS; Burn J; Boyle JM Oncogene; 1998 Jun; 16(25):3291-8. PubMed ID: 9681828 [TBL] [Abstract][Full Text] [Related]
17. Li-Fraumeni syndrome in a Turkish family. Karakas Z; Tugcu D; Unuvar A; Atay D; Akcay A; Gedik H; Kayserili H; Dogan O; Anak S; Devecioglu O Pediatr Hematol Oncol; 2010 May; 27(4):297-305. PubMed ID: 20426520 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family. Schiffman JD; Chun N; Fisher PG; Dahl GV; Ford JM; Eggerding FA Pediatr Blood Cancer; 2008 Apr; 50(4):914-6. PubMed ID: 17554785 [TBL] [Abstract][Full Text] [Related]
19. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Varley JM; McGown G; Thorncroft M; Santibanez-Koref MF; Kelsey AM; Tricker KJ; Evans DG; Birch JM Cancer Res; 1997 Aug; 57(15):3245-52. PubMed ID: 9242456 [TBL] [Abstract][Full Text] [Related]
20. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin. Bendig I; Mohr N; Kramer F; Weber BH Cancer Genet Cytogenet; 2004 Oct; 154(1):22-6. PubMed ID: 15381368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]